Physostigmine
Physostigmine is a medication used for the treatment of anticholinergic toxicity caused by drugs such as atropine and certain antihistamines. It belongs to the reversible acetylcholinesterase inhibitor class of drugs. It works by inhibiting the enzyme acetylcholinesterase, thereby increasing acetylcholine levels in the brain and peripheral nervous system. This helps reverse symptoms such as confusion, hallucinations, dilated pupils, and urinary retention. Physostigmine is available in injectable and ophthalmic formulations. Common side effects include nausea, vomiting, sweating, and increased salivation. Serious adverse effects may include seizures, bradycardia, and cardiac arrhythmias. It should be administered under strict medical supervision with continuous cardiac monitoring.
Physostigmine was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Physostigmine, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Physostigmine from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Physostigmine, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
